STXS (Stereotaxis) Cyclically Adjusted Revenue per Share: $0.73 (As of Mar. 2026)


STXS Stereotaxis Inc STXS
67 GF Score
Price $1.74
GF Value $2.33
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Stereotaxis Cyclically Adjusted Revenue per Share?

Stereotaxis STXS -3.33% 67 Cyclically Adjusted Revenue per Share is $0.73 as of Mar. 2026. GuruFocus rates STXS with a GF Score™ of 67/100 and a GF Value™ of $2.33 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Stereotaxis's adjusted revenue per share for the three months ended in Mar. 2026 was $0.064. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.73 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Stereotaxis's average Cyclically Adjusted Revenue Growth Rate was -18.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -20.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -23.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -22.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Stereotaxis was -8.60% per year. The lowest was -27.90% per year. And the median was -21.35% per year.

As of today (2026-07-09), Stereotaxis's current stock price is $1.74. Stereotaxis's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $0.73. Stereotaxis's Cyclically Adjusted PS Ratio of today is 2.38.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Stereotaxis was 3.88. The lowest was 0.07. And the median was 1.24.


Stereotaxis  (AMEX:STXS) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Stereotaxis's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.74/0.73
=2.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Stereotaxis was 3.88. The lowest was 0.07. And the median was 1.24.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Stereotaxis Cyclically Adjusted Revenue per Share Related Terms


Stereotaxis Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Stereotaxis's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stereotaxis Cyclically Adjusted Revenue per Share Chart

Stereotaxis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.14 1.49 1.11 0.94 0.76

Stereotaxis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 0.86 0.81 0.76 0.73

STXS vs PDEX, KRMD, EMBC: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Stereotaxis's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stereotaxis Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Stereotaxis's Cyclically Adjusted PS Ratio falls into.


STXS
67GF Score
Stereotaxis Inc STXS
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stereotaxis Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Stereotaxis's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.064/330.2130*330.2130
=0.064

Current CPI (Mar. 2026) = 330.2130.

Stereotaxis Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.361 241.018 0.495
201609 0.381 241.428 0.521
201612 0.333 241.432 0.455
201703 0.312 243.801 0.423
201706 0.375 244.955 0.506
201709 0.358 246.819 0.479
201712 0.331 246.524 0.443
201803 0.210 249.554 0.278
201806 0.128 251.989 0.168
201809 0.128 252.439 0.167
201812 0.123 251.233 0.162
201903 0.118 254.202 0.153
201906 0.113 256.143 0.146
201909 0.128 256.759 0.165
201912 0.101 256.974 0.130
202003 0.082 258.115 0.105
202006 0.075 257.797 0.096
202009 0.117 260.280 0.148
202012 0.091 260.474 0.115
202103 0.115 264.877 0.143
202106 0.120 271.696 0.146
202109 0.120 274.310 0.144
202112 0.109 278.802 0.129
202203 0.093 287.504 0.107
202206 0.081 296.311 0.090
202209 0.101 296.808 0.112
202212 0.096 296.797 0.107
202303 0.086 301.836 0.094
202306 0.097 305.109 0.105
202309 0.095 307.789 0.102
202312 0.055 306.746 0.059
202403 0.082 312.332 0.087
202406 0.053 314.175 0.056
202409 0.107 315.301 0.112
202412 0.073 315.605 0.076
202503 0.085 319.799 0.088
202506 0.100 322.561 0.102
202509 0.081 324.800 0.082
202512 0.090 324.054 0.092
202603 0.064 330.213 0.064

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.73 mean?
Stereotaxis (STXS) has a Cyclically Adjusted Revenue per Share of $0.73 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Stereotaxis and its competitors.
Is Stereotaxis' Cyclically Adjusted Revenue per Share too high?
Stereotaxis' current Cyclically Adjusted Revenue per Share is $0.73. Overall, Stereotaxis has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stereotaxis' Cyclically Adjusted Revenue per Share compare to PDEX and KRMD?
Stereotaxis' Cyclically Adjusted Revenue per Share of $0.73 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Stereotaxis and its competitors. Stereotaxis's current Cyclically Adjusted Revenue per Share is $0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stereotaxis stock overvalued right now?
Based on GuruFocus' analysis, Stereotaxis (STXS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.33, compared to a current price of $1.74 — trading 25.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is $0.73. Stereotaxis' overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Stereotaxis (STXS), the current Cyclically Adjusted Revenue per Share is $0.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stereotaxis (STXS) Overvalued in 2026?

Based on GuruFocus' analysis, Stereotaxis stock appears to be undervalued. The current stock price of $1.74 is trading 25.3% below its estimated GF Value™ of $2.33. GuruFocus considers Stereotaxis to be Modestly Undervalued.

Key valuation signals for STXS:

  • Cyclically Adjusted Revenue per Share: $0.73
  • GF Value™: $2.33 vs. price of $1.74 (25.3% below fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the STXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stereotaxis Business Description

Other Exchanges RJR1:Germany
Address 710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
67GF Score

Get the complete analysis for STXS

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.74
Price
$2.33
GF Value